Most Recent
Construction PRO
Builder, developer off hook for $3M in fire safety repairs
A Bechara family-affiliated builder and developer of a 99-lot residential building in a Sydney suburb have avoided liability for $3 million in fire safety rectification costs.
Judge facing recusal bid clarifies relationship with litigation funder
A judge presiding over a class action against Fletcher Building has clarified his relationship with the director of a litigation funder which is the basis of a recusal bid.
Google’s ad tech dominance probed by second class action firm
A second law firm has launched a class action investigation into Google’s dominance in the online advertising exchange, alleging breaches of competition laws. 
AMP class action ‘in search of a case’ after four years, court told
AMP has won its bid for more information on a class action’s allegations that it charged excessive insurance premiums, saying the applicant appeared to be “in search of a case”.
NSW Police can’t appeal ruling on names in strip search class action
The NSW government can't appeal a decision that denied its bid to subpoena the names of 2,316 registered group members in a class action over allegedly unlawful strip searches at music festivals. 
Judge OKs cutting edge argument in $900M class action against CBA
A judge has allowed a class action against CBA and its former wealth management arm Colonial First State to add claims based on a novel theory of corporate responsibility that has implications for companies’ use of AI.
Real estate listings giant REA accuses rival Domain of scraping its data
News Corp-owned REA Group has sued rival real estate portal Domain, accusing its main competitor of infringing the copyright it owns in property photos and floor plans.
Allergan hit with class action over breast implants linked to cancer
US drug company Allergan is facing a class action on behalf of women implanted with textured breast implants that were recalled after they were linked to a form of non-Hodgkin lymphoma. 
Bayer launches High Court appeal to revive Xarelto patents
Bayer has filed a High Court challenge to a decision that invalidated its patents for blockbuster blood thinner Xarelto, saying it would adversely affect drug research and development.
‘Replete with error’: Firm fights $5.4M security order in Macquarie class action
A law firm is challenging an order that it pay $5.4 million in a class action against Macquarie Leasing as security for the lender's costs, saying concerns about its borrowing capacity were “theoretical and speculative.”